ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

139 hedge funds and large institutions have $1.19B invested in Intra-Cellular Therapies Inc. in 2016 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 16 closing their positions.

Holders
139
Holders Change
+12
Holders Change %
+9.45%
% of All Funds
3.71%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
29
Increased
58
Reduced
28
Closed
16
Calls
$22.7M
Puts
$14.6M
Net Calls
+$8.1M
Net Calls Change
+$13.5M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$91.4M
2
BB
2
BB Biotech
Switzerland
$27.2M
3
O
3
OrbiMed
New York
$34.4M
4
EC
4
EcoR1 Capital
California
$9.51M
5
Norges Bank
5
Norges Bank
Norway
$7.65M

Top Sellers

1
VAM
1
Visium Asset Management
New York
$209K
2
Millennium Management
2
Millennium Management
New York
$24.1M
3
EAM
3
EverPoint Asset Management
Connecticut
$11.6M
4
SAM
4
Senzar Asset Management
New York
$5.61M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$252M 6,484,897 +8,591 +0.1%
Vanguard Group
2
Vanguard Group
Pennsylvania
$91.4M 2,355,713 +781,550 +50%
TCM
3
TimesSquare Capital Management
New York
$62.9M 1,619,875 +95,500 +6%
Jennison Associates
4
Jennison Associates
New York
$49.7M 1,279,597 +1,987 +0.2%
BA
5
BlackRock Advisors
Delaware
$48.8M 1,257,910 -12,062 -0.9%
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$42.7M 1,100,000 – –
BFA
7
BlackRock Fund Advisors
California
$40.5M 1,043,100 +72,160 +7%
RG
8
Redmile Group
California
$37.7M 971,565 -84,494 -8%
O
9
OrbiMed
New York
$34.4M 885,400 +591,400 +201%
WA
10
Wasatch Advisors
Utah
$31.5M 811,812 +10,776 +1%
BIT
11
BlackRock Institutional Trust
California
$30.6M 788,743 +67,349 +9%
State Street
12
State Street
Massachusetts
$30.4M 783,959 -47,338 -6%
BB
13
BB Biotech
Switzerland
$27.2M 700,000 +700,000 New
SCM
14
Sarissa Capital Management
Connecticut
$26.2M 675,000 – –
Millennium Management
15
Millennium Management
New York
$24.1M 619,937 -614,093 -50%
BBA
16
Baker Bros. Advisors
New York
$23.6M 609,166 – –
CCI
17
Columbus Circle Investors
$21.4M 552,104 +157,498 +40%
BG
18
BlackRock Group
United Kingdom
$18.9M 485,620 -187 -0%
Morgan Stanley
19
Morgan Stanley
New York
$16.1M 415,267 +9,785 +2%
Northern Trust
20
Northern Trust
Illinois
$15.2M 392,471 +72,356 +23%
GGHC
21
Gilder Gagnon Howe & Co
New York
$11.7M 300,952 +9,620 +3%
EAM
22
EverPoint Asset Management
Connecticut
$11.6M 300,000 -350,000 -54%
Franklin Resources
23
Franklin Resources
California
$9.82M 253,000 – –
EC
24
EcoR1 Capital
California
$9.51M 244,950 +244,950 New
CS
25
Candriam SCA
Luxembourg
$8.89M 229,000 +95,000 +71%
1
2 3 4 5